“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about SpringWorks Therapeutics
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers
| C-Level 5 | VP - Level15 |
| Director118 | Manager77 |
| Others104 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| <first>@ | John@springworkstx.com |
| <first>.<last>@ | John.Smith@springworkstx.com |
| <first><last>@ | JohnSmith@springworkstx.com |
SpringWorks Therapeutics looking to hire in Application Development in Los Angeles, CA
SpringWorks Therapeutics looking to hire in Application Development in NAMER
SpringWorks Therapeutics looking to hire in Account Payable in Stamford, CT
Aws
Coldfusion
Dxc
Gcp
Google analytics
Agile
Azure devops
Devops
Infrastructure management
Access management
Merck KGaA raised $4B via low-coupon bonds and acquired SpringWorks to expand in high-margin rare disease markets. - Strategic debt leverage maintains
Read MoreMerck has completed its previously announced $3.4bn acquisition of SpringWorks Therapeutics, a biopharmaceutical company based in Stamford.
Read MoreMerck (NSE:PROR) KGaA, Darmstadt, Germany, has completed its acquisition of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a company with strong financial
Read MoreA little over two months after it was announced, Germany-based life sciences firm Merck KGaA said Tuesday that it has completed its $3.9 billion acquisition
Read MoreSpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers
Springworks therapeutics operates in the Biotechnology research industry.
Springworks therapeutics's revenue is $191.59m
Springworks therapeutics has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.